1.
Forštnarič A, Stajan A, Piko N. Balancing the Benefits and Risks of SGLT2 Inhibitors: Koristi in pasti zdravljenja s SGLT-2 zaviralci. AMB [Internet]. 2026 Jun. 19 [cited 2026 Aug. 21];19(1):10-7. Available from: https://journals.um.si/index.php/amb/article/view/5972